- ICH GCP
- Rejestr badań klinicznych UE
Najnowsze wersje próbne
EudraCT Number: 2005-001084-56 | Sponsor Protocol Number: DSC/04/2357/10 | Start Date: 2005-05-27 | |||||||||||
Sponsor Name: ITALFARMACO | |||||||||||||
Full Title: Phase II Multiple-Dose Clinical Trial of Oral ITF 2357 In Patients with Advanced Multiple Myeloma | |||||||||||||
Medical condition: multiple myeloma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-000395-41 | Sponsor Protocol Number: ICORG 05-01 | Start Date: 2005-05-27 | ||||||
Sponsor Name: All Ireland co-operative Oncology Research Group | ||||||||
Full Title: Phase II Study to Assess the Safety, Efficacy, and Tolerability of Combination Therapy with Velcade (Bortezomib), Adriamycin, and Dexamethasone (PAD) as Therapy for Patients with relapsed or refra... | ||||||||
Medical condition: Relapsed or refractory Multiple Myeloma | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: GB (GB - no longer in EU/EEA) IE (Completed) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2005-001202-60 | Sponsor Protocol Number: 09/05 | Start Date: 2005-05-26 | ||||||
Sponsor Name: Organisation name was not entered | ||||||||
Full Title: Metotreksaatti aksiaalisen spondyloartropatian hoidossa | ||||||||
Medical condition: Aksiaalinen spondyloartropatia (varhainen selkärankareuma) | ||||||||
|
||||||||
Population Age: Adults | Gender: Male, Female | |||||||
Trial protocol: FI (Ongoing) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-003835-30 | Sponsor Protocol Number: | Start Date: 2005-05-26 | ||||||
Sponsor Name: Belfast City Hospital | ||||||||
Full Title: An open label, single centre, assessor blind pilot study comparing topical tacrolimus 0.1% and hydrocortisone ointment 1% in the treatment of flexural psoriasis | ||||||||
Medical condition: flexural psoriasis | ||||||||
|
||||||||
Population Age: Adults | Gender: Female | |||||||
Trial protocol: GB (Prematurely Ended) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000930-35 | Sponsor Protocol Number: MHE100901 | Start Date: 2005-05-26 | |||||||||||
Sponsor Name: GLAXO SMITHKLINE | |||||||||||||
Full Title: An open-label extension study to study 100185, to evaluate long-term safety, efficacy and optimal dosing frequency of 750mg intravenous mepolizumab in subjects with hypereosinophilic syndrome. | |||||||||||||
Medical condition: HES | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-005148-28 | Sponsor Protocol Number: 25643 | Start Date: 2005-05-26 | |||||||||||
Sponsor Name: Merck Serono International S.A. | |||||||||||||
Full Title: A phase III, randomised, double-blind, three-arm, placebo-controlled, multi-center study to evaluate the safety and efficacy of oral Cladribine in subjects with relapsing remitting multiple sclerosis | |||||||||||||
Medical condition: Relapsing-remitting multiple sclerosis (RRMS) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) GB (Completed) DK (Completed) EE (Completed) CZ (Completed) BE (Completed) IT (Completed) AT (Completed) SK (Completed) LT (Completed) DE (Completed) LV (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-001466-14 | Sponsor Protocol Number: MEN002 | Start Date: 2005-05-26 | ||||||
Sponsor Name: University of Dundee | ||||||||
Full Title: A Proof of Concept Study to Investigate the use of Simvastatin as a Putative Anti-inflammatory Agent in Asthma | ||||||||
Medical condition: Asthma | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: GB (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-002147-27 | Sponsor Protocol Number: | Start Date: 2005-05-26 | ||||||
Sponsor Name: Department of General Psychiatry | ||||||||
Full Title: Influence of treatment of olanzapine and ziprasidone on transcapillary glucose transport in human skeletal muscle | ||||||||
Medical condition: Healthy volunteers | ||||||||
|
||||||||
Population Age: Adults | Gender: Male | |||||||
Trial protocol: AT (Completed) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004321-95 | Sponsor Protocol Number: AMLSG 07-04 | Start Date: 2005-05-26 | ||||||
Sponsor Name: University of Ulm | ||||||||
Full Title: RANDOMIZED PHASE II-STUDY ON VALPROIC ACID, ALL-TRANS RETINOIC ACID AND THEIR COMBINATION IN INDUCTION AND CONSOLIDATION THERAPY AS WELL AS PEGFILGRASTIM AFTER CONSOLIDATION THERAPY IN YOUNGER PATI... | ||||||||
Medical condition: newly diagnosed acute myeloid leukemia | ||||||||
|
||||||||
Population Age: Adults | Gender: Male, Female | |||||||
Trial protocol: AT (Ongoing) | ||||||||
Trial results: View results |
EudraCT Number: 2004-005088-17 | Sponsor Protocol Number: CZOL446EHU03 | Start Date: 2005-05-26 | ||||||
Sponsor Name: Novartis Hungária Ltd. | ||||||||
Full Title: A multicenter, Open-label Study to Determine the Effect of I.V. Zometa on Pain and Quality of Life in Patients with Bone Metastases with or without Skeletal Related Events (SREs) Resulting from Bre... | ||||||||
Medical condition: Patients will have bone metastases with or without skeletal related events (SREs) from breast cancer and prostate cancer. | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: HU (Completed) | ||||||||
Trial results: View results |